Arcturus Therapeutics Holdings (ARCT) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $12.0 million.
- Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization rose 890.65% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 890.65%. This contributed to the annual value of $11.8 million for FY2024, which is 3513.73% up from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported Accumulated Depreciation & Amortization of $12.0 million as of Q3 2025, which was up 890.65% from $13.4 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Accumulated Depreciation & Amortization high stood at $13.4 million for Q2 2025, and its period low was $3.4 million during Q1 2021.
- Over the past 5 years, Arcturus Therapeutics Holdings' median Accumulated Depreciation & Amortization value was $7.1 million (recorded in 2023), while the average stood at $7.7 million.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization surged by 5147.17% in 2023 and then surged by 890.65% in 2025.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization stood at $4.3 million in 2021, then skyrocketed by 35.88% to $5.8 million in 2022, then skyrocketed by 51.13% to $8.7 million in 2023, then soared by 35.14% to $11.8 million in 2024, then rose by 1.35% to $12.0 million in 2025.
- Its Accumulated Depreciation & Amortization was $12.0 million in Q3 2025, compared to $13.4 million in Q2 2025 and $12.6 million in Q1 2025.